| Literature DB >> 28919019 |
Nicolas Skrypek1, Steven Goossens2, Eva De Smedt3, Niels Vandamme4, Geert Berx5.
Abstract
Epithelial-to-mesenchymal transition (EMT) is a process in which epithelial cells lose their junctions and polarity to gain a motile mesenchymal phenotype. EMT is essential during embryogenesis and adult physiological processes like wound healing, but is aberrantly activated in pathological conditions like fibrosis and cancer. A series of transcription factors (EMT-inducing transcription factor; EMT-TF) regulate the induction of EMT by repressing the transcription of epithelial genes while activating mesenchymal genes through mechanisms still debated. The nuclear interaction of EMT-TFs with larger protein complexes involved in epigenetic genome modulation has attracted recent attention to explain functions of EMT-TFs during reprogramming and cellular differentiation. In this review, we discuss recent advances in understanding the interplay between epigenetic regulators and EMT transcription factors and how these findings could be used to establish new therapeutic approaches to tackle EMT-related diseases.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28919019 DOI: 10.1016/j.tig.2017.08.004
Source DB: PubMed Journal: Trends Genet ISSN: 0168-9525 Impact factor: 11.639